Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/1 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Canaccord John Newman Downgrade Hold (from buy) -11% $95.74 Newman also lowered his …

    Published on 5/4/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/24 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Canaccord Corey Davis Downgrade Hold (from buy) -62% $12.87 Needham Serge Belanger…

    Published on 4/27/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/17 cls Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) H.C. Wainwright Swayampakula Ramakanth Upgrade Buy (from neutral) 23% $0.64 …

    Published on 4/20/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/10 cls Bruker Corp. (NASDAQ:BRKR) Leerink Partners Dan Leonard Upgrade Outperform (from market perform) 7% $20.18 Leonard also …

    Published on 4/13/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/2 cls Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF) ROTH Capital Partners Joseph Pantginis Downgrade Neutral (from buy) -58%…

    Published on 4/6/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/27 cls Exact Sciences Corp. (NASDAQ:EXAS) Goldman Sachs Isaac Ro Downgrade Neutral (from buy) -7% $22.49 Ro also lowered his target…

    Published on 3/30/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/20 cls Actelion Ltd. (SIX:ATLN) UBS Guillaume van Renterghem Downgrade Neutral (from buy) 4% CHF 118.90 van Renterghem downgraded …

    Published on 3/23/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/13 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Cowen Boris Peaker Downgrade Market perform (from outperform) -54% $4.06 Jefferies…

    Published on 3/16/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/6 cls Achaogen Inc. (NASDAQ:AKAO) Credit Suisse Jason Kantor Downgrade Underperform (from outperform) -8% $10.32 Kantor also …

    Published on 3/9/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/27 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Mizuho Mario Corso Upgrade Buy (from neutral) 9% $8.86 Corso also raised his …

    Published on 3/2/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/20 cls Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) Cantor Fitzgerald Irina Rivkind Koffler Price target Buy 61% $33.68 William Blair …

    Published on 2/23/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/13 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) MLV Raghuram Selvaraju New Buy -11% $36.14 Selvaraju initiated coverage with a $58 …

    Published on 2/16/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/6 cls Affymetrix Inc. (NASDAQ:AFFX) JPMorgan Tycho Peterson Upgrade Neutral (from underweight) 3% $11.38 Peterson also raised his …

    Published on 2/9/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/30 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Price target Outperform 9% $389.16 Deutsche Bank Robyn …

    Published on 2/2/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/23 cls Arrowhead Research Corp. (NASDAQ:ARWR) Deutsche Bank Alethia Young Downgrade Hold (from buy) -6% $6.43 Young also lowered …

    Published on 1/26/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/16 cls Depomed Inc. (NASDAQ:DEPO) Roth Capital Partners Scott Henry Upgrade Buy (from neutral) 17% $20.20 Henry also raised his …

    Published on 1/19/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/9 cls Cempra Inc. (NASDAQ:CEMP) Needham Alan Carr Price target Buy 13% $25.78 Carr raised his target to $42 from $28 after oral …

    Published on 1/12/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/2 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Downgrade Neutral (from outperform) 4% $13.33 Skorney …

    Published on 1/5/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/19 cls BioDelivery Sciences International Inc. (NASDAQ:BDSI) Roth Capital Partners Scott Henry Upgrade Buy (from neutral) 0% $13.82…

    Published on 12/22/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/12 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Credit Suisse Jason Kantor Downgrade Underperform (from neutral) -14% $6.34 Kantor…

    Published on 12/15/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/5 cls Bind Therapeutics Inc. (NASDAQ:BIND) Credit Suisse Jason Kantor Downgrade Neutral (from outperform) -12% $5.74 Kantor also …

    Published on 12/8/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/21 cls Alimera Sciences Inc. (NASDAQ:ALIM) Summer Street Jim Molloy New Buy 2% $5.37 Molloy initiated coverage with a $12 target …

    Published on 11/24/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/14 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Canaccord John Newman New Buy 17% $84.06 Newman initiated coverage with a $97 …

    Published on 11/17/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/7 cls Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) H.C. Wainwright Swayampakula Ramakanth Downgrade Neutral (from buy) -47% C$0.66…

    Published on 11/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/31 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Deutsche Bank Robyn Karnauskas Downgrade Hold (from buy) -34% $20.19 Jefferies…

    Published on 11/3/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993